$133.31

+2.00 (+1.52%)

Weekly Expected Move ±4.6%

$108 $113 $119 $124 $130

NASDAQ · Healthcare · Medical - Instruments & Supplies · Alpha Radar Buy · Power 61 · $3.3B mcap · 25M float · 1.17% daily turnover · Short 67% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$2.2B -6.4% ▼

5Y CAGR: +11.9%

Gross Profit

$820M -0.6% ▼

5Y CAGR: +12.2%

Operating Income

$107M +148.9% ▲

5Y CAGR: +1.7%

Net Income

$732K +100.6% ▲

5Y CAGR: -61.5%

EPS (Diluted)

$0.03 +100.6% ▲

5Y CAGR: -62.6%

EBITDA

$327M +660.0% ▲

5Y CAGR: +11.0%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.3B	$2.3B	$2.3B	$2.4B	$2.2B
YoY Growth	+3.6%	+73.2%	-0.9%	+5.4%	-6.4%
Cost of Revenue	$825M	$1.6B	$1.5B	$1.6B	$1.4B
Gross Profit	$491M	$698M	$740M	$825M	$820M
Gross Margin	37.3%	30.6%	32.8%	34.6%	36.8%
R&D Expenses	$47M	$93M	$85M	$89M	$87M
SG&A Expenses	$303M	$608M	$607M	$639M	$625M
Operating Expenses	$368M	$741M	$717M	$782M	$713M
Operating Income	$123M	-$43M	$23M	$43M	$107M
Operating Margin	9.4%	-1.9%	1.0%	1.8%	4.8%
Interest Expense	$858K	$71M	$103M	$107M	$105M
Income Before Tax	$123M	-$114M	-$78M	-$66M	$3M
Tax Expense	$20M	-$40M	-$49M	$52M	$2M
Net Income	$103M	-$74M	-$30M	-$118M	$732K
Net Margin	7.8%	-3.3%	-1.3%	-4.9%	0.0%
EPS (Diluted)	$4.74	$-3.11	$-1.23	$-4.83	$0.03
EBITDA	$223M	$192M	$253M	$43M	$327M
Shares Outstanding	22M	24M	24M	24M	25M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$596M	$589M	$630M	$605M	$549M	$537M	$540M	$530M
Cost of Revenue	$389M	$384M	$403M	$395M	$341M	$336M	$338M	$357M
Gross Profit	$207M	$205M	$227M	$210M	$208M	$201M	$202M	$173M
Gross Margin	34.8%	34.8%	36.1%	34.7%	37.9%	37.4%	37.4%	32.6%
R&D Expenses	$23M	$21M	$22M	$23M	$22M	$21M	$21M	$21M
SG&A Expenses	$160M	$163M	$159M	$157M	$159M	$153M	$156M	$155M
Operating Expenses	$200M	$197M	$190M	$197M	$197M	$187M	$177M	$142M
Operating Income	$8M	$8M	$38M	$13M	$11M	$14M	$25M	$31M
Operating Margin	1.3%	1.4%	6.0%	2.1%	1.9%	2.6%	4.7%	5.8%
Interest Expense	$27M	$27M	$26M	$29M	$23M	$20M	$25M	-$16M
Income Before Tax	-$20M	-$18M	$8M	-$11M	$37M	-$4M	-$18M	-$5M
Tax Expense	$2M	$15M	$32M	$5M	$1M	-$658K	-$3M	-$35M
Net Income	-$21M	-$33M	-$24M	-$15M	$35M	-$3M	-$16M	$30M
Net Margin	-3.6%	-5.6%	-3.8%	-2.6%	6.4%	-0.6%	-2.9%	5.7%
EPS (Diluted)	$-0.88	$-1.35	$-0.97	$-0.63	$1.43	$-0.14	$-0.64	$1.20
EBITDA	$62M	$65M	$87M	$64M	$106M	$67M	$61M	$81M
Shares Outstanding	24M	24M	24M	25M	25M	25M	25M	25M

ICUI NASDAQ